Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Updates in Surgery
Published in: Updates in Surgery 1/2015

01-03-2015 | Original Article

Surgery for isolated liver metastases from pancreatic cancer

Authors: Nicola Zanini, Raffaele Lombardi, Michele Masetti, Marco Giordano, Giovanni Landolfo, Elio Jovine

Published in: Updates in Surgery | Issue 1/2015

Login to get access

Abstract

The resection of liver metastases from pancreatic ductal adenocarcinoma has been discouraged because it is commonly thought that it does not improve survival. However, the role of potential prognostic factors is unclear, and universally accepted strategies have not been proposed. Between 2003 and 2014, 15 patients with isolated synchronous or metachronous metastases from pancreatic cancer underwent liver resection in our department. The role of potential prognostic factors was analyzed to predict survival. One right hepatectomy, 1 bisegmentectomy and 13 wedge resections were performed. Eleven patients underwent simultaneous pancreatic and liver resection for synchronous disease. The median overall survival (OS) was 9.1 months (95 % CI 8.6–9.7). The only potential prognostic factor that significatively affected survival was the timing of metastases (metachronous vs. synchronous). Median OS in patients with metachronous disease was 11.4 months (95 % CI 0–25.1) vs. 8.3 months (95 % CI 6.9–9.7), p = 0.038. Surgery for liver metastases from pancreatic cancer is not suggested for most patients. If resection is considered, timing of metastatic disease could be a prognostic factor for survival after surgery.
Literature
1.
2.
Shukla PJ (2011) The challenges of improving survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 254(2):385–386CrossRefPubMed
3.
Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R et al (2009) EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 45(6):931–991CrossRefPubMed
4.
Seton-Rogers S (2012) Navigating uncharted territory. Nat Rev Cancer 12:151PubMed
5.
Paez D, Labonte MJ, Lenz HJ (2012) Pancreatic cancer: medical management (novel chemotherapeutics). Gastroenterol Clin N Am 41:189–209CrossRef
6.
Takada T, Yasuda H, Amano H, Yoshida M, Uchida T (1997) Simultaneous pancreatic resection with pancreato-duodenectomy for metastatic pancreatic head carcinoma: does it improve survival? Hepatogastroenterology 44(14):567–573PubMed
7.
O’Rourke TR, Tekkis P, Yeung S, Fawcett J, Lynch S, Strong R et al (2008) Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol 15(1):207–218CrossRefPubMed
8.
Rehders A, Peiper M, Stoecklein NH, Alexander A, Boelke E, Knoefel WT et al (2009) Hepatic metastasectomy for soft-tissue sarcomas: is it justified? World J Surg 33(1):111–117CrossRefPubMed
9.
Chua TC, Saxena A, Liauw W, Chu F, Morris DL (2011) Hepatic resection for metastatic breast cancer: a systematic review. Eur J Cancer 47(15):2282–2290CrossRefPubMed
10.
Hatzaras I, Gleisner AL, Pulitano C, Sandroussi C, Hirose K, Hyder O et al (2012) A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB (Oxford) 14(8):532–538CrossRef
11.
Takemura N, Saiura A, Koga R, Arita J, Yoshioka R, Ono Y et al (2012) Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg 397(6):951–957CrossRefPubMed
12.
Kollmar O, Moussavian MR, Richter S, Bolli M, Schilling MK (2008) Surgery of liver metastasis in gynecological cancer—indication and results. Onkologie 31(7):375–379CrossRefPubMed
13.
Ercolani G, Ravaioli M, Grazi GL, Cescon M, Varotti G, Del Gaudio M et al (2006) The role of liver resections for metastases from lung carcinoma. HPB (Oxford) 8(2):114–115CrossRef
14.
Michalski CW, Erkan M, Hüser N, Müller MW, Hartel M, Friess H et al (2008) Resection of primary pancreatic cancer and liver metastasis: a systematic review. Dig Surg 25:473–480CrossRefPubMed
15.
16.
Thomas RM, Truty MJ, Nogueras-Gonzalez GM, Fleming JB, Vauthey JN, Pisters PW et al (2012) Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg 16:1696–1704CrossRefPubMed
17.
Shrikhande SV, Kleeff J, Reiser C, Weitz J, Hinz U, Esposito I et al (2006) Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol 14:118–127CrossRefPubMed
18.
Contreras CM, Stanelle EJ, Mansour J, Hinshaw JL, Rikkers LF, Rettammel R et al (2009) Staging laparoscopy enhances the detection of occult metastases in patients with pancreatic adenocarcinoma. J Surg Oncol 100(8):663–669CrossRefPubMed
19.
Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13CrossRefPubMed
20.
Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR et al (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the international study group of pancreatic surgery (ISGPS). Surgery 142:761–768CrossRefPubMed
21.
22.
Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F et al (2012) EMT and dissemination precede pancreatic tumor formation. Cell 148(1–2):349–356CrossRefPubMedCentralPubMed
23.
Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F (2012) Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 148:362–375CrossRefPubMedCentralPubMed
24.
Assifi MM, Lu X, Eibl G, Reber HA, Li G, Hines OJ (2011) Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials. Surgery 150:466–473CrossRefPubMedCentralPubMed
25.
Papalezova KT, Tyler DS, Blazer DG 3rd, Clary BM, Czito BG, Hurwitz HI et al (2012) Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer? J Surg Oncol 106:111–118CrossRefPubMed
26.
Wolff RA (2012) Neoadjuvant therapy for resectable and unresectable adenocarcinoma of the pancreas. Curr Drugs Targets 13:781–788CrossRef
27.
Gunturu KS, Jarboe J, Saif MW (2012) Highlights on the first line treatment of metastatic pancreatic cancer. JOP 13:361–367PubMed
28.
Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817–1825CrossRefPubMed
29.
Gleisner AL, Assumpcao L, Cameron JL, Wolfgang CL, Choti MA, Herman JM et al (2007) Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified? Cancer 110:2484–2492CrossRefPubMed
30.
Seelig SK, Burkert B, Chromik AM, Tannapfel A, Uhl W, Seelig MH (2010) Pancreatic resections for advanced M1-pancreatic carcinoma: the value of synchronous metastasectomy. HPB Surg 2010:579–672CrossRef
31.
32.
Smith MD, McCall JL (2009) Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases. Br J Surg 96:1101–1112CrossRefPubMed
33.
Elias D, Liberale G, Vernerey D, Pocard M, Ducreux M, Boige V et al (2005) Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter but their total number has prognostic effect. Ann Surg Oncol 12:900–909CrossRefPubMed
34.
Miller G, Biernacki P, Kemeny NE, Gonen M, Downey R, Jarnagin WR et al (2007) Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg 205:231–238CrossRefPubMed
35.
Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M et al (2006) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 244:524–535CrossRefPubMedCentralPubMed
36.
Iida T, Nakabayashi Y, Okui N, Shiba H, Otsuka M, Yanaga K (2014) Successful management of metachronous liver metastasis after pancreaticoduodectomy for pancreatic ductal carcinoma using hepatectomy and chemotherapy: a case report. Anticancer Res 34(5):2417–2420PubMed
37.
Shakir AR (2014) A near-complete response to treatment with gemcitabine plus nab (®)-paclitaxel in a patient with metastatic pancreatic cancer and poor performance status: a case report. Case Rep Oncol 7(3):711–717CrossRefPubMedCentralPubMed
38.
Andriulli A, Festa V, Botteri E, Valvano MR, Koch M, Bassi C, Maisonneuve P et al (2012) Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies. Ann Surg Oncol 19(5):1644–1662CrossRefPubMed
Metadata
Title
Surgery for isolated liver metastases from pancreatic cancer
Authors
Nicola Zanini
Raffaele Lombardi
Michele Masetti
Marco Giordano
Giovanni Landolfo
Elio Jovine
Publication date
01-03-2015
Publisher
Springer Milan
Published in
Updates in Surgery / Issue 1/2015
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-015-0283-6

Other articles of this Issue 1/2015

Updates in Surgery 1/2015 Go to the issue

Original Article

The unreliability of continuous postoperative lactate monitoring after extended hepatectomies: single center experience

Original Article

Splenic flexure colon cancers: minimally invasive treatment

Letter to the Editor

Metastasis in lymph nodes on the anterior pancreatic surface of the body and tail: an extremely rare finding during bursectomy in extended surgery for gastric cancer

Editorial

Message from the Editors-in-Chief

Original Article

Tracheoesophageal fistula in adults due to corrosive ingestion: challenges in management

Review Article

Local anaesthetic infiltration for the rubber band ligation of early symptomatic haemorrhoids: a systematic review and meta-analysis